New hope for dialysis patients battling anemia
NCT ID NCT03402386
Summary
This study tested a drug called MT-6548 for treating anemia (low red blood cells) in people with chronic kidney disease who use peritoneal dialysis. It involved 42 participants in Japan to see if the drug was effective at raising and keeping hemoglobin levels in a healthy range and to check its safety. The goal was to offer better management of this common and tiring complication of kidney failure.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANEMIA; PERITONEAL DIALYSIS DEPENDENT CHRONIC KIDNEY DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Research site
Aichi, Japan
-
Research site
Chiba, Japan
-
Research site
Fukuoka, Japan
-
Research site
Fukushima, Japan
-
Research site
Gunma, Japan
-
Research site
Hokkaido, Japan
-
Research site
Hyōgo, Japan
-
Research site
Ibaraki, Japan
-
Research site
Kagoshima, Japan
-
Research site
Kanagawa, Japan
-
Research site
Kyoto, Japan
-
Research site
Nagano, Japan
-
Research site
Nara, Japan
-
Research site
Okayama, Japan
-
Research site
Okinawa, Japan
-
Research site
Shiga, Japan
-
Research site
Tokyo, Japan
Conditions
Explore the condition pages connected to this study.